Zambon Pharma

Last updated: 10.01.2019


Zambon is a leading pharmaceutical and chemical multinational. Founded in 1906 in Italy, Zambon operates directly on three continents – Europe, North & South America and Asia. It has 2500 employees spread in 14 countries and consolidated sales of €483m.

Zambon Company S.p.A. is the holding company of the Zambon Group, consisting of fine chemicals company ZaCh System, pharmaceuticals multinational Zambon S.p.A. and corporate venture specialist Z-Cube the corporate venture arm of the group which has launched three start-up companies  — PharmEste s.r.l., SuppreMol GmbH and ProtAffin Biotechnologie AG.

Z-Cube is a corporate company of Zambon Company S.p.A. focused on DDT exploitation. They convert promising technologies from university laboratories or early start-ups into a number of commercial opportunities, to generate revenue growth for all parties involved.

ZaCh System’s expertise and proprietary patents in process chemistry are wide-ranging, extending from asymmetric transformation and resolution to solid state analysis and control, the multistep synthesis of complex APIs and separation and purification.

In recent years, Zambon has entered a new growth phase with a renewed path to provide innovative solutions to improve patients’ quality of life, with a specialization in treating severe diseases such as Parkinson’s and Cystic Fibrosis.


We use cookies to ensure that we give you the best experience on our site. For more info click here